GlassScriptPhysician profile
Louis A Aliperti
NPI 1861810350
$6,888.10
in general payments reported to CMS, 2019-2025
52 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $449 · 2021: $774 · 2022: $961 · 2023: $1,506 · 2024: $1,176 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,011 · Education: $55.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,011.21 |
| Education | $55.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,056.51 | 2019-2025 | Lumenis Pulse 120h, Lithoclast |
| Urogen Pharma, INC. | $563.38 | 2023-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $444.10 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $390.70 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $354.54 | 2021-2025 | Provenge |
| Accord Healthcare, INC. | $330.50 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $287.96 | 2022-2024 | Prolaris |
| Teleflex LLC | $273.53 | 2021-2023 | Urolift |
| Ferring Pharmaceuticals INC. | $261.46 | 2022-2025 | Adstiladrin |
| Astellas Pharma US INC | $249.38 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $240.82 | 2023-2025 | Aquabeam Robotic System |
| Coloplast Corp | $190.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $181.57 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Cook Medical LLC | $174.29 | 2019 | |
| Olympus America INC. | $129.39 | 2023 | Itind System |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Aliperti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.